Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
J Hosp Infect ; 77(1): 25-30, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21129820

ABSTRACT

This study evaluated three methods for monitoring hospital cleanliness. The aim was to find a benchmark that could indicate risk to patients from a contaminated environment. We performed visual monitoring, ATP bioluminescence and microbiological screening of five clinical surfaces before and after detergent-based cleaning on two wards over a four-week period. Five additional sites that were not featured in the routine domestic specification were also sampled. Measurements from all three methods were integrated and compared in order to choose appropriate levels for routine monitoring. We found that visual assessment did not reflect ATP values nor environmental contamination with microbial flora including Staphylococcus aureus and meticillin-resistant S. aureus (MRSA). There was a relationship between microbial growth categories and the proportion of ATP values exceeding a chosen benchmark but neither reliably predicted the presence of S. aureus or MRSA. ATP values were occasionally diverse. Detergent-based cleaning reduced levels of organic soil by 32% (95% confidence interval: 16-44%; P<0.001) but did not necessarily eliminate indicator staphylococci, some of which survived the cleaning process. An ATP benchmark value of 100 relative light units offered the closest correlation with microbial growth levels <2.5 cfu/cm(2) (receiver operating characteristic ROC curve sensitivity: 57%; specificity: 57%). In conclusion, microbiological and ATP monitoring confirmed environmental contamination, persistence of hospital pathogens and measured the effect on the environment from current cleaning practices. This study has provided provisional benchmarks to assist with future assessment of hospital cleanliness. Further work is required to refine practical sampling strategy and choice of benchmarks.


Subject(s)
Benchmarking/methods , Disinfection/methods , Hospitals , Housekeeping, Hospital/methods , Infection Control/methods , Adenosine Triphosphate/analysis , Bacteria/isolation & purification , Bacteria/metabolism , Bacterial Load , Cross Infection/prevention & control , Environmental Microbiology , Humans
2.
J Hosp Infect ; 74(1): 62-71, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19819583

ABSTRACT

This study compared the bacterial removal performance of ultramicrofibre cloths and mops (UMF) moistened with water (UMF+water), with those moistened with a novel copper-based biocide (UMF+CuWB50, 300ppm) in several working hospital environments, specifically accident and emergency (A&E) and three other wards. A total of 13 defined sampling sites (10 sites per ward) were sampled in order to retrieve, culture, and enumerate total viable (bacterial) counts (TVC) for each site. We sampled 1h before, and 1 and 4h after, cleaning three times per week. The trial ran for 7 weeks. Two wards were cleaned with UMF+water for 3 weeks, and UMF+CuWB50 for 4 weeks. The reverse applied to the other two wards in a cross-over design fashion, to eliminate ward- and time-specific bias. Multivariate statistical analyses were used to establish extent and significance of any perceived differences, and to eliminate the effects of potential confounders. Cleaning with UMF+water reduced TVC on the test surfaces by 30%, whereas cleaning with TVC+CuWB50 reduced TVC by 56%. CuWB50 had two separate effects; a direct antibacterial effect (evident shortly after cleaning), and a residual antibacterial effect that lasted approximately 2 weeks. The residual effect requires regular application of CuWB50 if it is to persist. This 'real life' hospital implementation study demonstrates encouraging microbiological cleaning performance for UMF, which is further enhanced with CuWB50.


Subject(s)
Bacteria/drug effects , Copper/pharmacology , Disinfectants/pharmacology , Disinfection/methods , Microbial Viability/drug effects , Textiles/microbiology , Colony Count, Microbial , Cross-Over Studies , Hospitals , Humans , Infection Control/methods
3.
Nanotechnology ; 19(3): 035506, 2008 Jan 23.
Article in English | MEDLINE | ID: mdl-21817574

ABSTRACT

Electrically charged cellular polymers are known to display pseudo-piezoelectric effects that endow them with interesting mechano-electrical characteristics. When a film of such a polymer is compressed, charge is generated across its thickness, and conversely, applying an oscillatory or static potential elicits mechanical motions. This dual sensor-actuator behaviour can be embedded in one material and presents distinct advantages of functional integration. A novel electroactive foam is presented here that embeds such a sensor-actuator function. The foam has a sensitivity constant (d(33)) of 330 pC N(-1). Interestingly, the resonant behaviour of the cellular film can be altered by variation in the DC offset across the material. Such adaptive capacity could be of great advantage for tuning polymer-based mechanical devices to be either efficient sound radiators and mechanical actuators, or sensitive and coherent sensors. Possible applications in microfluidics are also discussed.

4.
Mol Cell Biol ; 21(22): 7576-86, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11604494

ABSTRACT

Most mitochondrial proteins are synthesized with cleavable amino-terminal targeting signals that interact with the mitochondrial import machinery to facilitate their import from the cytosol. We previously reported that the presequence of the F(1)-ATPase beta subunit precursor (pre-F(1)beta) acts as an intramolecular chaperone that maintains the precursor in an import-competent conformation prior to import (P. Hajek, J. Y. Koh, L. Jones, and D. M. Bedwell, Mol. Cell. Biol. 17:7169-7177, 1997). We also found that a mutant form of pre-F(1)beta with a minimal targeting signal (Delta 1,2 pre-F(1)beta) is inefficiently imported into mitochondria because it rapidly folds into an import-incompetent conformation. We have now analyzed the consequences of reducing the pre-F(1)beta targeting signal to a minimal unit in more detail. We found that Delta 1,2 pre-F(1)beta is more dependent upon the Tom70p receptor for import than WT pre-F(1)beta is, resulting in a growth defect on a nonfermentable carbon source at 15 degrees C. Experiments using an in vitro mitochondrial protein import system suggest that Tom70p functions to maintain a precursor containing the Delta 1,2 pre-F(1)beta import signal in an import-competent conformation. We also identified PDR3, a transcriptional regulator of the pleiotropic drug resistance network, as a multicopy suppressor of the mitochondrial import defects associated with Delta 1,2 pre-F(1)beta in a tom70 Delta strain. The overproduction of PDR3 mediated this effect by increasing the import of Delta 1,2 pre-F(1)beta into mitochondria. This increased the mitochondrial ATP synthase activity to the extent that growth of the mutant strain was restored under the selective conditions. Analysis of the transcription patterns of components of the mitochondrial outer membrane import machinery demonstrated that PDR3 overproduction increased the expression of TOM72, a little studied TOM70 homologue. These results suggest that Tom72p possesses overlapping functions with Tom70p and that the pleiotropic drug resistance network plays a previously unappreciated role in mitochondrial biogenesis.


Subject(s)
DNA-Binding Proteins/biosynthesis , Fungal Proteins/physiology , Gene Expression Regulation, Fungal , Membrane Proteins/physiology , Membrane Transport Proteins/genetics , Mitochondria/metabolism , Saccharomyces cerevisiae Proteins/genetics , Transcription Factors/biosynthesis , Amino Acid Sequence , Biological Transport , DNA-Binding Proteins/metabolism , Enzyme Precursors/metabolism , Fungal Proteins/genetics , Fungal Proteins/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mitochondrial Membrane Transport Proteins , Mitochondrial Precursor Protein Import Complex Proteins , Molecular Sequence Data , Mutagenesis , Proton-Translocating ATPases/metabolism , RNA, Fungal/metabolism , RNA, Messenger/metabolism , Trans-Activators/metabolism
5.
Am J Respir Crit Care Med ; 163(7): 1683-92, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11401894

ABSTRACT

Here we report the effects of gentamicin treatment on cystic fibrosis transmembrane regulator (CFTR) production and function in CF airway cells and patients with CF with premature stop mutations. Using immunocytochemical and functional [6-methoxy-N- (3-sulfopropyl) quinolinium (SPQ)-based] techniques, ex vivo exposure of airway cells from stop mutation CF patients led to the identification of surface-localized CFTR in a dose-dependent fashion. Next, five patients with CF with stop mutations and five CF control subjects were treated with parenteral gentamicin for 1 wk, and underwent repeated in vivo measures of CFTR function (nasal potential difference [PD] measurements and sweat chloride [Cl(-)] testing). During the treatment period, the number of nasal PD readings in the direction of Cl(-) secretion was increased approximately 3-fold in the stop mutation patient group compared with controls (p < 0.001), and four of five stop mutation patients with CF had at least one reading during gentamicin treatment with a Cl(-) secretory response of more than -5 mV (hyperpolarized). A response of this magnitude was not seen in any of the CF control subjects (p < 0.05). In an independent series of experiments designed to test the ability of repeat nasal PDs to detect wild-type CFTR function, evidence of Cl(-) secretion was seen in 88% of control (non-CF) nasal PDs, and 71% were more than -5 mV hyperpolarized. Together, these results suggest that gentamicin treatment can suppress premature stop mutations in airway cells from patients with CF, and produce small increases in CFTR Cl(-) conductance (as measured by the nasal PD) in vivo.


Subject(s)
Codon, Nonsense/drug effects , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis/genetics , Gentamicins/pharmacology , Adolescent , Adult , Cells, Cultured , Chlorides/metabolism , Cystic Fibrosis/metabolism , Cystic Fibrosis/physiopathology , Cystic Fibrosis Transmembrane Conductance Regulator/biosynthesis , Cystic Fibrosis Transmembrane Conductance Regulator/physiology , Female , Gentamicins/administration & dosage , Humans , Infusions, Intravenous , Male , Membrane Potentials , Microscopy, Fluorescence , Nasal Mucosa/metabolism , Nasal Mucosa/physiopathology
6.
Hum Mol Genet ; 10(3): 291-9, 2001 Feb 01.
Article in English | MEDLINE | ID: mdl-11159948

ABSTRACT

Hurler syndrome is the most severe form of a lysosomal storage disease caused by loss of the enzyme alpha-L-iduronidase (encoded by the IDUA gene), which participates in the degradation of glycosaminoglycans (GAGs) within the lysosome. In some populations, premature stop mutations represent roughly two-thirds of the mutations that cause Hurler syndrome. In this study we investigated whether the aminoglycoside gentamicin can suppress stop mutations within the IDUA gene. We found that a Hurler syndrome fibroblast cell line heterozygous for the IDUA stop mutations Q70X and W402X showed a significant increase in alpha-L-iduronidase activity when cultured in the presence of gentamicin, resulting in the restoration of 2.8% of normal alpha-L-iduronidase activity. Determination of alpha-L-iduronidase protein levels by an immunoquantification assay indicated that gentamicin treatment produced a similar increase in alpha-L-iduronidase protein in Hurler cells. Both the alpha-L-iduronidase activity and protein level resulting from this treatment have previously been correlated with mild Hurler phenotypes. Although Hurler fibroblasts contain a much higher level of GAGs than normal, we found that gentamicin treatment reduced GAG accumulation in Hurler cells to a normal level. We also found that a reduced GAG level could be sustained for at least 2 days after gentamicin treatment was discontinued. The reduction in the GAG level was also reflected in a marked reduction in lysosomal vacuolation. Taken together, these results suggest that the suppression of premature stop mutations may provide an effective treatment for Hurler syndrome patients with premature stop mutations in the IDUA gene.


Subject(s)
Anti-Bacterial Agents/pharmacology , Gentamicins/pharmacology , Glycosaminoglycans/metabolism , Iduronidase/drug effects , Lysosomes/drug effects , Mucopolysaccharidosis I/enzymology , Cell Line , Codon, Terminator/genetics , Dose-Response Relationship, Drug , Fibroblasts/drug effects , Fibroblasts/enzymology , Fibroblasts/metabolism , HSP70 Heat-Shock Proteins/drug effects , HSP70 Heat-Shock Proteins/metabolism , Humans , Iduronidase/genetics , Iduronidase/metabolism , Lysosomes/metabolism , Mucopolysaccharidosis I/genetics , Mucopolysaccharidosis I/pathology , Mutation
7.
Anal Biochem ; 284(1): 1-5, 2000 Aug 15.
Article in English | MEDLINE | ID: mdl-10933848

ABSTRACT

Pathophysiological levels of oxygen radical metabolites have been studied as indicators of trauma caused by burn insult. The 2, 3-diaminonaphthalene assay is routinely used in the determination of nitrite/nitrate levels in biological fluids and cellular extracts as one indicator of nitric oxide activity. Several laboratories, including ours, have noted matrix-based interferences resulting in decreased assay sensitivity during nitrite/nitrate analysis. We evaluated filtration using Millipore Ultrafree-MC 10,000 NMWL filters for the ability to eliminate matrix-based interferences from human serum and tissue culture medium, thereby restoring assay sensitivity.


Subject(s)
Filtration/methods , Nitrates/analysis , Nitrites/analysis , Ultrafiltration/methods , 2-Naphthylamine/analogs & derivatives , 2-Naphthylamine/analysis , Animals , Cattle , Dose-Response Relationship, Drug , Humans , Micropore Filters , Nitrates/blood , Nitrites/blood , Reproducibility of Results , Sensitivity and Specificity , Serum Albumin/pharmacology , Spectrometry, Fluorescence/methods
8.
RNA ; 6(7): 1044-55, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10917599

ABSTRACT

The translation machinery recognizes codons that enter the ribosomal A site with remarkable accuracy to ensure that polypeptide synthesis proceeds with a minimum of errors. When a termination codon enters the A site of a eukaryotic ribosome, it is recognized by the release factor eRF1. It has been suggested that the recognition of translation termination signals in these organisms is not limited to a simple trinucleotide codon, but is instead recognized by an extended tetranucleotide termination signal comprised of the stop codon and the first nucleotide that follows. Interestingly, pharmacological agents such as aminoglycoside antibiotics can reduce the efficiency of translation termination by a mechanism that alters this ribosomal proofreading process. This leads to the misincorporation of an amino acid through the pairing of a near-cognate aminoacyl tRNA with the stop codon. To determine whether the sequence context surrounding a stop codon can influence aminoglycoside-mediated suppression of translation termination signals, we developed a series of readthrough constructs that contained different tetranucleotide termination signals, as well as differences in the three bases upstream and downstream of the stop codon. Our results demonstrate that the sequences surrounding a stop codon can play an important role in determining its susceptibility to suppression by aminoglycosides. Furthermore, these distal sequences were found to influence the level of suppression in remarkably distinct ways. These results suggest that the mRNA context influences the suppression of stop codons in response to subtle differences in the conformation of the ribosomal decoding site that result from aminoglycoside binding.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cinnamates , Codon, Terminator/drug effects , Protein Biosynthesis/drug effects , Animals , Anti-Bacterial Agents/chemistry , Dose-Response Relationship, Drug , Escherichia coli/genetics , Genes, Reporter , Gentamicins/pharmacology , Humans , Hygromycin B/analogs & derivatives , Hygromycin B/pharmacology , Kanamycin/pharmacology , Neomycin/pharmacology , Paromomycin/analogs & derivatives , Paromomycin/pharmacology , Plasmids , RNA, Messenger/metabolism , Rabbits , Reticulocytes/drug effects , Reticulocytes/metabolism , Ribosomes/drug effects , Ribosomes/metabolism , Sisomicin/pharmacology , Streptomycin/pharmacology , Tobramycin/pharmacology
9.
J Biol Chem ; 275(8): 5431-40, 2000 Feb 25.
Article in English | MEDLINE | ID: mdl-10681519

ABSTRACT

Phosphoglucomutase (PGM) is a key enzyme in glucose metabolism, where it catalyzes the interconversion of glucose 1-phosphate (Glc-1-P) and glucose 6-phosphate (Glc-6-P). In this study, we make the novel observation that PGM is also involved in the regulation of cellular Ca(2+) homeostasis in Saccharomyces cerevisiae. When a strain lacking the major isoform of PGM (pgm2Delta) was grown on media containing galactose as sole carbon source, its rate of Ca(2+) uptake was 5-fold higher than an isogenic wild-type strain. This increased rate of Ca(2+) uptake resulted in a 9-fold increase in the steady-state total cellular Ca(2+) level. The fraction of cellular Ca(2+) located in the exchangeable pool in the pgm2Delta strain was found to be as large as the exchangeable fraction observed in wild-type cells, suggesting that the depletion of Golgi Ca(2+) stores is not responsible for the increased rate of Ca(2+) uptake. We also found that growth of the pgm2Delta strain on galactose media is inhibited by 10 microM cyclosporin A, suggesting that activation of the calmodulin/calcineurin signaling pathway is required to activate the Ca(2+) transporters that sequester the increased cytosolic Ca(2+) load caused by this high rate of Ca(2+) uptake. We propose that these Ca(2+)-related alterations are attributable to a reduced metabolic flux between Glc-1-P and Glc-6-P due to a limitation of PGM enzymatic activity in the pgm2Delta strain. Consistent with this hypothesis, we found that this "metabolic bottleneck" resulted in an 8-fold increase in the Glc-1-P level compared with the wild-type strain, while the Glc-6-P and ATP levels were normal. These results suggest that Glc-1-P (or a related metabolite) may participate in the control of Ca(2+) uptake from the environment.


Subject(s)
Calcium/pharmacokinetics , Phosphoglucomutase/chemistry , Saccharomyces cerevisiae/enzymology , Carboxypeptidases/metabolism , Cathepsin A , Endoplasmic Reticulum/metabolism , Galactose/metabolism , Glycoside Hydrolases/metabolism , Glycosylation , Golgi Apparatus/metabolism , Mutagenesis , Phenotype , Phosphoglucomutase/genetics , Protein Isoforms , Time Factors , beta-Fructofuranosidase
10.
J Biol Chem ; 274(48): 34396-402, 1999 Nov 26.
Article in English | MEDLINE | ID: mdl-10567418

ABSTRACT

The heat shock protein (Hsp) 70/Hsp40 chaperone system plays an essential role in cell physiology, but few of its in vivo functions are known. We report that biogenesis of Axl1p, an insulinase-like endoprotease from yeast, is dependent upon the cytosolic Hsp40 protein Ydj1p. Axl1 is responsible for cleavage of the P2 processing intermediate of pro-a-factor, a mating pheromone, to its mature form. Mutant ydj1 strains exhibited a severe mating defect, which correlated with a 90% reduction in a-factor secretion. Reduced levels of a-factor export were caused by defects in the endoproteolytic processing of P2, which led to its intracellular accumulation. Defective P2 processing correlated with the reduction in the steady state level of active Axl1p. Two mechanisms were uncovered to explain why Axl1p activity was diminished in ydj1 strains. First, AXL1 mRNA levels were reduced ydj1 strains. Second, the half-life of newly synthesized Axl1p was greatly diminished in ydj1 strains. Collectively, these data indicate Ydj1p functions to promote AXL1 mRNA accumulation and in addition appears to facilitate the proper folding of nascent Axl1p. This study is the first to suggest a role for Ydj1p in RNA metabolism and identifies Axl1p as an in vivo substrate of the Hsp70/Ydj1p chaperone system.


Subject(s)
Fungal Proteins/biosynthesis , Glycoproteins , HSP70 Heat-Shock Proteins/genetics , Peptides/metabolism , Protein Precursors/metabolism , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/genetics , ATP-Binding Cassette Transporters/metabolism , Binding Sites , Fungal Proteins/genetics , Fungal Proteins/metabolism , Gene Expression Regulation, Fungal , Genetic Complementation Test , HSP40 Heat-Shock Proteins , HSP70 Heat-Shock Proteins/chemistry , HSP70 Heat-Shock Proteins/metabolism , Heat-Shock Proteins/genetics , Mating Factor , Metalloendopeptidases , Molecular Chaperones/genetics , Mutation , Protein Processing, Post-Translational , Protein Structure, Tertiary , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae/metabolism
11.
FEBS Lett ; 451(2): 132-6, 1999 May 21.
Article in English | MEDLINE | ID: mdl-10371152

ABSTRACT

It is well established that the vacuole plays an important role in the cellular adaptation to growth in the presence of elevated extracellular Ca2+ concentrations in Saccharomyces cerevisiae. The Ca2+ ATPase Pmc1p and the Ca2+/H+ exchanger Vcx1p/Hum1p have been shown to facilitate Ca2+ sequestration into the vacuole. However, the distinct physiological roles of these two vacuolar Ca2+ transporters remain uncertain. Here we show that Vcx1p can rapidly sequester a sudden pulse of cytosolic Ca2+ into the vacuole, while Pmc1p carries out this function much less efficiently. This finding is consistent with the postulated role of Vcx1p as a high capacity, low affinity Ca2+ transporter and suggests that Vcx1p may act to attenuate the propagation of Ca2+ signals in this organism.


Subject(s)
Antiporters/physiology , Calcium-Binding Proteins/physiology , Calcium/metabolism , Cation Transport Proteins , Cytosol/metabolism , Ion Exchange , Macrolides , Saccharomyces cerevisiae Proteins , Vacuoles/metabolism , Aequorin/metabolism , Anti-Bacterial Agents/pharmacology , Calcium-Transporting ATPases/physiology , Enzyme Inhibitors/pharmacology , Fungal Proteins/physiology , Mutagenesis , Plasma Membrane Calcium-Transporting ATPases , Saccharomyces cerevisiae , Time Factors
12.
J Biol Chem ; 274(9): 5939-47, 1999 Feb 26.
Article in English | MEDLINE | ID: mdl-10026219

ABSTRACT

The vacuole is the major site of intracellular Ca2+ storage in yeast and functions to maintain cytosolic Ca2+ levels within a narrow physiological range. In this study, we examined how cellular Ca2+ homeostasis is maintained in a vps33Delta vacuolar biogenesis mutant. We found that growth of the vps33Delta strain was sensitive to high or low extracellular Ca2+. This strain could not properly regulate cytosolic Ca2+ levels and was able to retain only a small fraction of its total cellular Ca2+ in a nonexchangeable intracellular pool. Surprisingly, the vps33Delta strain contained more total cellular Ca2+ than the wild type strain. Because most cellular Ca2+ is normally found within the vacuole, this suggested that other intracellular compartments compensated for the reduced capacity to store Ca2+ within the vacuole of this strain. To test this hypothesis, we examined the contribution of the Golgi-localized Ca2+ ATPase Pmr1p in the maintenance of cellular Ca2+ homeostasis. We found that a vps33Delta/pmr1Delta strain was hypersensitive to high extracellular Ca2+. In addition, certain combinations of mutations effecting both vacuolar and Golgi Ca2+ transport resulted in synthetic lethality. These results indicate that the Golgi apparatus plays a significant role in maintaining Ca2+ homeostasis when vacuolar biogenesis is compromised.


Subject(s)
Calcium/metabolism , Golgi Apparatus/metabolism , Homeostasis , Mutation , Saccharomyces cerevisiae/metabolism , Vacuoles/metabolism , Adenosine Triphosphatases/metabolism , Base Sequence , Cytosol/metabolism , DNA Primers , Golgi Apparatus/enzymology , Magnesium/metabolism , Oxidative Stress , Phosphates/metabolism , Saccharomyces cerevisiae/genetics
13.
Biochemistry ; 37(43): 15222-30, 1998 Oct 27.
Article in English | MEDLINE | ID: mdl-9790686

ABSTRACT

The cystic fibrosis transmembrane conductance regulator (CFTR) is a member of the traffic ATPase family that includes multiple proteins characterized by (1) ATP binding, (2) conserved transmembrane (TM) motifs and nucleotide binding domains (NBDs), and (3) molecular transport of small molecules across the cell membrane. While CFTR NBD-1 mediates ATP binding and hydrolysis, the membrane topology and function of this domain in living eukaryotic cells remains uncertain. In these studies, we have expressed wild-type CFTR NBD-1 (amino acids 433-586) or NBD-1 containing the DeltaF508 mutation transiently in COS-7 cells and established that the domain is situated across the plasma membrane by four independent assays; namely, extracellular chymotrypsin digestion, surface protein biotinylation, confocal immunofluorescent microscopy, and functional measurements of cell membrane anion permeability. Functional studies indicate that basal halide permeability is enhanced above control conditions following wild-type or DeltaF508 NBD-1 expression in three different epithelial cell lines. Furthermore, when clinically relevant CFTR proteins truncated within NBD-1 (R553X or G542X) are expressed, surface localization and enhanced halide permeability are again established. Together, these findings suggest that isolated CFTR NBD-1 (with or without the DeltaF508 mutation) is capable of targeting the epithelial cell membrane and enhancing cellular halide permeability. Furthermore, CFTR truncated at position 553 or 542 and possessing the majority of NBD-1 demonstrates surface localization and also confers increased halide permeability. These findings indicate that targeting to the plasma membrane and assumption of a transmembrane configuration are innate properties of the CFTR NBD-1. The results also support the notion that components of the halide-selective pore of CFTR reside within NBD-1.


Subject(s)
Adenosine Triphosphate/metabolism , Cell Membrane Permeability , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Epithelial Cells/metabolism , Peptide Fragments/metabolism , Animals , Anions , Arginine/genetics , COS Cells , Cell Line , Cell Membrane/metabolism , Cell Membrane/physiology , Cell Membrane Permeability/genetics , Codon, Terminator/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/physiology , Epithelial Cells/physiology , Glycine/genetics , Humans , Mice , Mutagenesis, Site-Directed , Peptide Fragments/biosynthesis , Peptide Fragments/genetics , Protein Binding , Protein Structure, Tertiary
14.
Mol Cell Biol ; 17(12): 7169-77, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9372949

ABSTRACT

Mitochondrial import signals have been shown to function in many steps of mitochondrial protein import. Previous studies have shown that the F1-ATPase beta-subunit precursor (pre-F1beta) of the yeast Saccharomyces cerevisiae contains an extended, functionally redundant mitochondrial import signal at its amino terminus. However, the full significance of this functionally redundant targeting sequence has not been determined. We now report that the extended pre-F1beta signal acts to maintain the precursor in an import-competent conformation prior to import, in addition to its previously characterized roles in mitochondrial targeting and translocation. We found that this extended signal is required for the efficient posttranslational mitochondrial import of pre-F1beta both in vivo and in vitro. To determine whether the pre-F1beta signal directly influences precursor conformation, fusion proteins that contain wild-type and mutant forms of the pre-F1beta import signal attached to the model passenger protein dihydrofolate reductase (DHFR) were constructed. Deletions that reduced the import signal to a minimal functional unit decreased both the half-time of precursor folding and the efficiency of mitochondrial import. To confirm that the reduced mitochondrial import associated with this truncated signal was due to a defect in its ability to maintain DHFR in a loosely folded conformation, we introduced structurally destabilizing missense mutations into the DHFR passenger to block precursor folding independently of the import signal. We found that the truncated signal imported this destabilized form of DHFR as efficiently as the intact targeting signal, indicating that the primary defect associated with the minimal signal is an inability to maintain the precursor in a loosely folded conformation. Our results suggest that the loss of this intramolecular chaperone function leads to defects in the early stages of the import process.


Subject(s)
Fungal Proteins/metabolism , Mitochondria/metabolism , Proton-Translocating ATPases/chemistry , Proton-Translocating ATPases/metabolism , Adult , Amino Acid Sequence , Base Sequence , Biological Transport, Active , Enzyme Precursors/chemistry , Enzyme Precursors/genetics , Enzyme Precursors/metabolism , Humans , Kinetics , Models, Biological , Molecular Chaperones/metabolism , Molecular Sequence Data , Mutation , Oligodeoxyribonucleotides/genetics , Protein Conformation , Protein Folding , Protein Sorting Signals/chemistry , Protein Sorting Signals/genetics , Protein Sorting Signals/metabolism , Proton-Translocating ATPases/genetics , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Tetrahydrofolate Dehydrogenase/chemistry , Tetrahydrofolate Dehydrogenase/genetics , Tetrahydrofolate Dehydrogenase/metabolism
15.
Nat Med ; 3(11): 1280-4, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9359706

ABSTRACT

Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR) protein. While 70% of CF chromosomes carry a deletion of the phenylalanine residue 508 (deltaF508) of CFTR, roughly 5% of all CF chromosomes carry a premature stop mutation. We reported that the aminoglycoside antibiotics G-418 and gentamicin can suppress two premature stop mutations [a stop codon in place of glycine residue 542 (G542X) and arginine residue 553 (R553X)] when expressed from a CFTR cDNA in HeLa cells. Suppression resulted in the synthesis of full-length CFTR protein and the appearance of a cAMP-activated anion conductance characteristic of CFTR function. However, it was unclear whether this approach could restore CFTR function in cells expressing mutant forms of CFTR from the nuclear genome. We now report that G-418 and gentamicin are also capable of restoring CFTR expression in a CF bronchial epithelial cell line carrying the CFTR W1282X premature stop mutation (a stop codon in place of tryptophan residue 1282). This conclusion is based on the reappearance of cAMP-activated chloride currents, the restoration of CFTR protein at the apical plasma membrane, and an increase in the abundance of CFTR mRNA levels from the W1282X allele.


Subject(s)
Bronchi/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Epithelial Cells/metabolism , Mutation , Alleles , Arginine/genetics , Bronchi/cytology , Cell Line , Cells, Cultured , Chloride Channels/metabolism , Codon, Terminator , Cyclic AMP/metabolism , Gene Deletion , HeLa Cells , Humans , RNA, Messenger/metabolism
16.
J Am Coll Health ; 45(5): 211-7, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9069679

ABSTRACT

Despite peer education's having become an extremely common strategy on many college campuses, very few outcome evaluations of these programs, particularly evaluations that focus on the peers themselves, have been performed. In this article, we report on a study that measured changes in self-esteem, personal development, and sexual behavior over 1 academic year in 65 sexuality peer educators from 10 universities in the United States. Objective measures of those traits demonstrated a shift in a positive direction; after analysis, however, the changes were not statistically significant. Qualitative data described increased levels of self-esteem, confidence, and safer sexual behavior as a major outcomes of the program, reinforcing the notion of the positive effects of peer education. Implications for program enhancement and considerations of the importance of evaluation are discussed, and recommendations for future research are offered.


Subject(s)
Peer Group , Sex Education , Student Health Services , Students/psychology , Adolescent , Adult , Analysis of Variance , Female , Humans , Male , Outcome Assessment, Health Care , Personality Inventory , Self Concept , Sexual Behavior , Surveys and Questionnaires
17.
Nat Med ; 2(4): 467-9, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8597960

ABSTRACT

Cystic fibrosis (CF) is caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR). A single recessive mutation, the deletion of phenylalanine 508 (deltaF508), causes severe CF and resides on 70% of mutant chromosomes. Severe CF is also caused by premature stop mutations, which are found on 5% of CF chromosomes. Here we report that two common, disease-associated stop mutations can be suppressed by treating cells with low doses of the aminoglycoside antibiotic G-418. Aminoglycoside treatment resulted in the expression of full-length CFTR and restored its cyclic AMP-activated chloride channel activity. Another aminoglycoside, gentamicin, also promoted the expression of full-length CFTR. These results suggest that treatment with aminoglycosides may provide a means of restoring CFTR function in patients with this class of mutation.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis/genetics , Gentamicins/pharmacology , Suppression, Genetic/drug effects , HeLa Cells , Humans , Mutation
18.
J Bacteriol ; 178(6): 1712-9, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8626301

ABSTRACT

Mating between the two haploid cell types (a and alpha) of the yeast Saccharomyces cerevisiae depends upon the efficient secretion and delivery of the a- and alpha-factor pheromones to their respective target cells. However, a quantitative correlation between the level of transported a-factor and mating efficiency has never been determined. a-Factor is transported by Ste6p, a member of the ATP-binding cassette (ABC) family of transporter proteins. In this study, several missense mutations were introduced in or near the conserved LSGGQ motif within the first nucleotide-binding domain of Ste6p. Quantitation of extracellular a-factor levels indicated that these mutations caused a broad range of a-factor transport defects, and those directly within the LSGGQ motif caused the most severe defects. Overall, we observed a strong correlation between the level of transported a-factor and the mating efficiency of these strains, consistent with the role of Ste6p as the a-factor transporter. The LSGGQ mutations did not cause either a significant alteration in the steady-state level of Ste6p or a detectable change in its subcellular localization. Thus, it appears that these mutations interfere with the ability of Ste6p to transport a-factor out of the MATa cell. The possible involvement of the LSGGQ motif in transporter function is consistent with the strong conservation of this sequence motif throughout the ABC transporter superfamily.


Subject(s)
ATP-Binding Cassette Transporters/genetics , Fungal Proteins/genetics , Fungal Proteins/metabolism , Glycoproteins , Lipoproteins/metabolism , Pheromones/metabolism , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/physiology , Amino Acid Sequence , Biological Transport , Cell Compartmentation , Molecular Sequence Data , Mutagenesis , Phenotype , Reproduction
19.
J Mol Biol ; 251(3): 334-45, 1995 Aug 18.
Article in English | MEDLINE | ID: mdl-7650736

ABSTRACT

In a recent study we found that the efficiency of translation termination could be decreased several hundred fold by altering the local sequence context surrounding stop codons in the yeast Saccharomyces cerevisiae. Suppression of termination was shown to be mediated by near-cognate tRNA mispairing with the termination codon. We have now examined in greater detail how the local sequence context affects the efficiency of translation termination in this organism. Our results indicate that the sequence immediately upstream of the termination codon plays a significant role in determining the efficiency of translation termination. An extended termination sequence (containing the stop codon and the following three nucleotides) was also found to be a major determinant of termination efficiency, with effects attributable to the fourth nucleotide being largely independent of the termination codon. For the UGA and UAA stop codons, the influence of the fourth position on termination efficiency (from most efficient to least efficient termination) was found to be G > U,A > C, while for the UAG codon it was U,A > C > G. These sequence-specific effects on the efficiency of translation termination suggest that polypeptide chain release factor (or another molecule that may play a role in translation termination, such as rRNA) recognizes an extended termination sequence in yeast. A previous study found a statistically significant bias toward certain tetranucleotide sequences (containing the stop codon and the first distal nucleotide) in several organisms. We found that tetranucleotide sequences most frequently used in yeast are among the most efficient at mediating translation termination, while rare tetranucleotide sequences mediate much less efficient termination. Taken together, our results indicate that upstream and downstream components of an extended sequence context act synergistically to determine the overall efficiency of translation termination in yeast.


Subject(s)
Codon, Terminator/genetics , Peptide Chain Termination, Translational/genetics , Regulatory Sequences, Nucleic Acid/genetics , Saccharomyces cerevisiae/genetics , Amino Acid Sequence , Base Sequence , DNA, Recombinant/genetics , Molecular Sequence Data , RNA, Fungal/biosynthesis , RNA, Messenger/biosynthesis , Suppression, Genetic , beta-Galactosidase/genetics
20.
J Bacteriol ; 177(11): 3087-94, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7768805

ABSTRACT

The enzyme phosphoglucomutase functions at a key point in carbohydrate metabolism. In this paper, we show that the synthesis of the major isoform of yeast phosphoglucomutase, encoded by the GAL5 (PGM2) gene, is regulated in a manner that is distinct from that previously described for other enzymes involved in galactose metabolism in the yeast Saccharomyces cerevisiae. Accumulation of this isoform increased four- to sixfold when the culture experienced either glucose depletion or heat shock. However, heat shock induction did not occur unless the cells were under glucose repression. This nonadditive increase in expression suggests that the regulatory mechanisms controlling the heat shock induction and glucose repression of the GAL5 gene are functionally related. We previously demonstrated that phosphoglucomutase is modified by a posttranslational Glc-phosphorylation reaction. We now show that this posttranslational modification, like phosphoglucomutase expression itself, is also regulated by galactose induction and glucose repression. Finally, no evidence was found to indicate that the Glc-phosphorylation of phosphoglucomutase alters its enzymatic activity under the conditions examined.


Subject(s)
Galactose/metabolism , Glucose/metabolism , Phosphoglucomutase/metabolism , Saccharomyces cerevisiae/enzymology , Base Sequence , Enzyme Induction , Gene Expression Regulation, Fungal , Glycogen/metabolism , Hot Temperature , Isoenzymes/metabolism , Molecular Sequence Data , Protein Processing, Post-Translational , RNA, Messenger/genetics , Transcription, Genetic , Trehalose/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...